Advertisement
Canada markets open in 39 minutes
  • S&P/TSX

    22,059.03
    -184.97 (-0.83%)
     
  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     
  • DOW

    39,375.87
    +67.87 (+0.17%)
     
  • CAD/USD

    0.7337
    +0.0005 (+0.07%)
     
  • CRUDE OIL

    82.72
    -0.44 (-0.53%)
     
  • Bitcoin CAD

    77,894.36
    -190.21 (-0.24%)
     
  • CMC Crypto 200

    1,223.92
    +57.80 (+4.96%)
     
  • GOLD FUTURES

    2,379.30
    -18.40 (-0.77%)
     
  • RUSSELL 2000

    2,026.73
    -9.89 (-0.49%)
     
  • 10-Yr Bond

    4.2880
    +0.0160 (+0.37%)
     
  • NASDAQ futures

    20,632.25
    +11.50 (+0.06%)
     
  • VOLATILITY

    12.60
    +0.12 (+0.96%)
     
  • FTSE

    8,227.37
    +23.44 (+0.29%)
     
  • NIKKEI 225

    40,780.70
    -131.67 (-0.32%)
     
  • CAD/EUR

    0.6765
    +0.0003 (+0.04%)
     

Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. Speaking of which, we noticed some great changes in Elevance Health's (NYSE:ELV) returns on capital, so let's have a look.

Understanding Return On Capital Employed (ROCE)

For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on Elevance Health is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.15 = US$10b ÷ (US$112b - US$44b) (Based on the trailing twelve months to March 2024).

ADVERTISEMENT

Thus, Elevance Health has an ROCE of 15%. On its own, that's a standard return, however it's much better than the 11% generated by the Healthcare industry.

View our latest analysis for Elevance Health

roce
roce

In the above chart we have measured Elevance Health's prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering Elevance Health for free.

How Are Returns Trending?

Elevance Health is displaying some positive trends. The numbers show that in the last five years, the returns generated on capital employed have grown considerably to 15%. Basically the business is earning more per dollar of capital invested and in addition to that, 30% more capital is being employed now too. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed.

The Bottom Line

A company that is growing its returns on capital and can consistently reinvest in itself is a highly sought after trait, and that's what Elevance Health has. And investors seem to expect more of this going forward, since the stock has rewarded shareholders with a 86% return over the last five years. In light of that, we think it's worth looking further into this stock because if Elevance Health can keep these trends up, it could have a bright future ahead.

One more thing, we've spotted 1 warning sign facing Elevance Health that you might find interesting.

While Elevance Health isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com